Apatinib Reverses Paclitaxel-resistant Lung Cancer Cells (A549) Through Blocking the Function of ABCB1 TransporterQuncheng Zhang(Zhengzhou University), Xiaoju Zhang(Henan University)Anticancer ResearchSeptember 30, 201910.21873/anticanres.13739Cited by 49SaveCiteExport RISWatch citationsRelated PapersTryptophan Metabolism Acts as a New Anti‐Ferroptotic Pathway to Mediate Tumor Growth|Advanced Science|2023|151N-Cadherin Expression Is Associated with Acquisition of EMT Phenotype and with Enhanced Invasion in Erlotinib-Resistant Lung Cancer Cell Lines|PLoS ONE|2013|130Chemoprophylaxis, diagnosis, treatments, and discharge management of COVID-19: An evidence-based clinical practice guideline (updated version)|Military Medical Research|2020|122